Case Studies

Featured

Abivax (ENXTPA:ABVX): Investor Relations Program

LifeSci has worked extensively with Abivax since 2015 to optimize and improve company positioning to actively increase visibility amongst investors and strategics internationally. With iterative updates to company materials, LifeSci strives to provide in depth updates and reviews of all internal and external content. LIFESCI’s ACTIVITIES Strengthened...

Read More
Verrica Pharmaceuticals (NASDAQ:VRCA): Investor Relations Program

BACKGROUND Verrica Pharmaceuticals has been a LifeSci client since December 2022. As part of the strategy to raise the Company’s visibility amongst global investors, LifeSci...

Read More
AlphaTau (NASDAQ:DRTS): Successful SPAC Transaction

BACKGROUND AlphaTau has been a LifeSci client since July 2021. As part of a strategy to raise visibility amongst investors, LifeSci organized over 60 virtual...

Read More
Abivax (ENXTPA:ABVX): Investor Relations Program

LifeSci has worked extensively with Abivax since 2015 to optimize and improve company positioning to actively increase visibility amongst investors and strategics internationally. With iterative...

Read More
Femasys (NASDAQ:FEMY): High-Net-Worth Event

BACKGROUND Femasys Inc. has been a LifeSci client since July 2021. As part of a strategy to raise the Company’s visibility amongst global investors, LifeSci...

Read More
InspireMD, Inc. (NASDAQ:NSPR): Investor Relations Program

InspireMD successfully completed a transformational Private Placement for up to $113.6 million, with $42.2 million financing upfront with up to an additional $71.4 million tied...

Read More
Orchestra Biomed (NASDAQ:OBIO): Investor Relations Program

Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. LIFESCI’s...

Read More

Questions for our team?